Indo-MIM IPO
Indo-MIM IPO — dates, price band, GMP & allotment.
Timetable
Issue Summary
| Price Band | ₹461-485 |
| Face Value | ₹1 |
| Lot Size | 30 Shares |
| Issue Size | ₹3811.21 Cr |
| Sale Type | Fresh capital cum OFS |
| Listing On | BSE, NSE |
| NSE Symbol | INDOMIM.NS |
| BSE Scrip Code | 7839 |
| Min Investment | ₹14,550 |
Reservation
What Will It Cost Me?
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹14,550 |
| Retail (Max) | 13 | 390 | ₹189,150 |
| S-HNI (Min) | 14 | 420 | ₹203,700 |
| B-HNI (Min) | 69 | 2,070 | ₹1,003,950 |
Strengths & Risks
Strengths
- World's largest installed Metal Injection Molding (MIM) capacity, with end-to-end capability from design to assembly
- Highly diversified customer base across automotive, defence, medical, aerospace and consumer sectors, reducing single-industry risk
- Strong revenue and profit growth, with PAT up 88% and total income up 49% between FY24 and FY26
- Global manufacturing footprint across India, the US, UK and Mexico supporting multinational customers
- Quality accreditations (NADCAP, IATF 16949, AS9100) enabling participation in regulated industries
Risks
- Operates on a purchase-order basis without binding long-term commitments from customers, creating revenue volatility risk
- Significant dependence on imported raw materials exposes the business to commodity price swings, currency fluctuations and geopolitical disruption
- Multi-plant operations across geographies face equipment, labour and operational disruption risks
- Elevated valuation at the upper price band, with a post-IPO P/E of about 44.95x and Price/Book of about 10.63x
- Large Offer-for-Sale component (Rs 3,312.11 Cr of the Rs 3,812.11 Cr issue), limiting fresh capital available for the company's own growth
Valuation & Key Ratios
Financials (Rs. Crore)
| Metric | 31 Mar 26 | 31 Mar 25 | 31 Mar 24 |
|---|---|---|---|
| Revenue | 4320.70 | 3373.97 | 2900.38 |
| OPM % | 24.79 | 27.64 | 25.63 |
| EBITDA | 1070.92 | 932.59 | 743.46 |
| Net Profit | 533.54 | 423.73 | 283.73 |
| Debt | 1090.49 | 1247.20 | 1085.01 |
| Assets | 4897.33 | 4140.84 | 3757.51 |
About The Company
Indo-MIM Limited, founded in 1996 and headquartered in Bengaluru, is the world's largest producer of Metal Injection Molding (MIM) components by installed capacity, holding roughly 6.8% of the global MIM market (2025). The company provides end-to-end precision engineering solutions spanning mold design, tooling, MIM, investment casting, precision machining, ceramic injection molding, metal 3D printing and assembly. It operates 15 manufacturing facilities across India, the United States, the United Kingdom and Mexico, serving more than 1,100 customers worldwide across the automotive, defence, medical, aerospace and consumer sectors. International markets accounted for about 77.2% of revenue in Fiscal 2026. The company holds NADCAP, IATF 16949 and AS9100 quality certifications supporting its presence in regulated industries.
Company & Registrar
Subscription By Category
| Category | Subscribed | Shares Offered | Shares Bid For |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 204.34× | 15,683,772 | — |
| Non-Institutional Investors (NII) | 50.63× | 11,762,829 | — |
| Retail Individual Investors (RII) | 6.67× | 27,446,600 | — |
| Employee | 9.44× | 200,000 | — |
| Total | 72.34× | 55,093,201 | — |
GMP History
| Date | GMP | % Over Issue Price |
|---|
Anchor Investors
| Investor | Category | Shares Allotted | Value |
|---|
Considering This IPO?
Talk to Alpha Funda about how an IPO application fits into your broader portfolio.
Get In Touch